[go: up one dir, main page]

PE20121503A1 - Estabilizacion de probioticos - Google Patents

Estabilizacion de probioticos

Info

Publication number
PE20121503A1
PE20121503A1 PE2012000257A PE2012000257A PE20121503A1 PE 20121503 A1 PE20121503 A1 PE 20121503A1 PE 2012000257 A PE2012000257 A PE 2012000257A PE 2012000257 A PE2012000257 A PE 2012000257A PE 20121503 A1 PE20121503 A1 PE 20121503A1
Authority
PE
Peru
Prior art keywords
probiotics
mixture
protein
stabilization
composition
Prior art date
Application number
PE2012000257A
Other languages
English (en)
Inventor
Najendra Rangavajla
Bolivar Cevallos
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43756845&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20121503(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PE20121503A1 publication Critical patent/PE20121503A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: UN PROBIOTICO QUE ESTA CONTENIDO EN UNA MEZCLA DE PROTEINA HIDROLIZADA TAL COMO CASEINA HIDROLIZADA, EN LA QUE POR LO MENOS 90% DE DICHA PROTEINA TIENE UN PESO MOLECULAR MENOR A 2000 DALTONS Y CONTIENE ENTRE 10% Y 20% DE LA MEZCLA DE COMPONENTES EN UNA BASE SECA, UNO O MAS CARBOHIDRATOS Y UN AGLUTINANTE COMPUESTO. DICHA COMPOSICION INCREMENTA LA ESTABILIDAD DE LOS PROBIOTICOS PRESENTANDO COMO VENTAJA PODER INCORPORARLOS EN PRODUCTOS NUTRICIONALES, TRANSPORTARLOS Y ALMACENARLOS POR UN TIEMPO EXTENDIDO SIN AFECTAR SU VIABILIDAD
PE2012000257A 2009-09-20 2010-09-17 Estabilizacion de probioticos PE20121503A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/563,157 US20110070334A1 (en) 2009-09-20 2009-09-20 Probiotic Stabilization

Publications (1)

Publication Number Publication Date
PE20121503A1 true PE20121503A1 (es) 2012-11-09

Family

ID=43756845

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000257A PE20121503A1 (es) 2009-09-20 2010-09-17 Estabilizacion de probioticos

Country Status (23)

Country Link
US (3) US20110070334A1 (es)
EP (2) EP2477638B1 (es)
JP (1) JP6240386B2 (es)
KR (1) KR20120068851A (es)
CN (4) CN102573862A (es)
AR (1) AR098598A1 (es)
AU (2) AU2010295508B2 (es)
BR (1) BR112012006220A2 (es)
CA (2) CA2772534A1 (es)
CO (1) CO6511231A2 (es)
EC (1) ECSP12011820A (es)
ES (1) ES2683310T3 (es)
IN (1) IN2012DN01440A (es)
MX (2) MX343446B (es)
MY (2) MY171199A (es)
NZ (1) NZ598520A (es)
PE (1) PE20121503A1 (es)
PH (2) PH12012500294B1 (es)
PL (1) PL2477638T3 (es)
RU (1) RU2012115658A (es)
SG (1) SG11201602868WA (es)
TW (2) TWI621707B (es)
WO (2) WO2011035093A1 (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP1973406B1 (en) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
JP5285617B2 (ja) 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
CN106987525B (zh) 2009-05-26 2020-10-27 先进生物营养公司 包含生物活性微生物和/或生物活性材料的稳定干粉组合物及其制造方法
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
RU2535869C2 (ru) 2010-01-28 2014-12-20 Эдванст Бионутришн Корпорейшн Сухая стекловидная композиция для стабилизации и защиты биологически активного материала и способ ее получения
PL2603100T3 (pl) 2010-08-13 2019-06-28 Advanced Bionutrition Corp. Kompozycja stabilizująca przechowywanie na sucho materiałów biologicznych
US20120135103A1 (en) * 2010-11-30 2012-05-31 Mead Johnson Nutrition Company Staged Infant Feeding Regimen To Promote Healthy Development And Growth
RU2748839C2 (ru) 2011-06-20 2021-05-31 Х.Дж. Хайнц Компани Брэндс Ллк Композиции, способы и наборы для стимулирования мукозальной иммунной системы
EA027508B1 (ru) * 2011-06-30 2017-08-31 Кр. Хансен А/С Стабильная сухая композиция молочнокислых бактерий
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
CA2861682C (en) * 2011-12-30 2017-07-25 Abbott Laboratories Concentrated low water activity liquid human milk fortifier including extensively hydrolyzed protein
CA2866889C (en) * 2012-03-23 2021-08-31 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US20130344042A1 (en) * 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
WO2014083177A1 (en) * 2012-11-29 2014-06-05 Nestec S.A. Synbiotic composition and use thereof
MX370692B (es) 2013-05-10 2019-12-19 Heinz Co Brands H J Llc Probióticos y métodos de uso.
US11274144B2 (en) 2013-06-13 2022-03-15 Research Institute At Nationwide Children's Hospital Compositions and methods for the removal of biofilms
AU2014357610B2 (en) * 2013-12-06 2017-10-12 Mjn U.S. Holdings Llc Probiotic stabilization
AU2015227075A1 (en) * 2014-03-06 2016-09-22 Ohio State Innovation Foundation Probiotic formulations and methods for use
US10624934B2 (en) * 2014-03-06 2020-04-21 Research Institute At Nationwide Children's Hospital Prebiotic formulations
WO2015140299A1 (en) * 2014-03-20 2015-09-24 Universiteit Antwerpen Oronasopharyngeal probiotics
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20150305384A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
KR101640744B1 (ko) * 2014-05-07 2016-07-19 일동제약주식회사 고분자 다당 바인더에 컨쥬게이트된 락토바실러스 람노서스 rht-3201, 및 이의 아토피 예방 및 치료 용도
US10946050B2 (en) 2015-03-16 2021-03-16 Imagilin Technology Llc Compositions comprising probiotics and methods of use thereof
US10195237B2 (en) 2015-03-16 2019-02-05 Imagilin Technology Llc Compositions and methods for treating inflammatory related diseases or conditions using Pediococcus acidilactici probiotics
US20170020165A1 (en) * 2015-07-22 2017-01-26 48th Parallel Incorporated Iso-alpha acid tinctures and carbonated beverage compositions including the same
MY194231A (en) * 2015-07-29 2022-11-23 Advanced Bionutrition Corp Stable dry probiotic compositions for special dietary uses
HK1255383A1 (zh) 2015-07-31 2019-08-16 The Research Institute At Nationwide Children's Hospital 去除生物膜的肽及抗體
WO2017066719A2 (en) 2015-10-14 2017-04-20 Research Institute At Nationwide Children's Hospital Hu specific interfering agents
EP3167895A1 (en) * 2015-11-10 2017-05-17 University College Dublin A dietary supplement comprising beta-glucan and casein hydrolysate for improving health and growth performance in a mammal
AU2016353091B2 (en) * 2015-11-10 2022-07-14 Probiotech Llc Probiotic delivery systems
JP7357326B2 (ja) * 2015-11-30 2023-10-06 イマジリン テクノロジー エルエルシー プロバイオティクスを含む組成物、及びその使用方法
KR102754888B1 (ko) 2015-12-04 2025-01-13 어드밴스드 바이오뉴트리션 코프. 당을 전혀 또는 거의 함유하지 않은 안정한 건조 조성물
TWI587863B (zh) * 2016-01-29 2017-06-21 Grape King Inc A probiotic entrapping particle
CN105661017A (zh) * 2016-02-03 2016-06-15 程雪娇 一种牲畜饲料及制备方法
US9855305B2 (en) 2016-03-29 2018-01-02 Companion Therapeutics Llc Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors
ES2797152T3 (es) * 2016-06-21 2020-12-01 Arla Foods Amba Procedimiento para la producción de productos nutricionales mejorados que contienen proteína láctea y sacáridos lácteos
EP3287145A1 (en) * 2016-08-26 2018-02-28 DuPont Nutrition Biosciences ApS Use of maltodextrin as an excipient
CN107744017A (zh) * 2017-06-27 2018-03-02 中食月太(北京)健康科技有限公司 一种含水解酪蛋白的益生菌固体饮料及其制备方法
CL2017003444A1 (es) * 2017-12-28 2018-05-18 Univ Santiago Chile Aditivo probiótico para alimento sólido deshidratado, preferentemente, cereal; método de preparación de dicho aditivo y alimento sólido deshidratado que lo contiene
US20190208807A1 (en) * 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
KR20200125966A (ko) 2018-03-15 2020-11-05 유니버시티 오브 써던 캘리포니아 염증 및 ibd 병리의 역전을 촉진하는, 물만 섭취하는 금식이 아닌 금식 모방 식이요법 (fmd)
AU2019258326B2 (en) * 2018-04-27 2024-03-07 Dsm Ip Assets B.V. Powderous composition comprising carotenoid and/or derivative thereof, D-glycose oligomere and modified polysaccharide as well as food, feed or personal care formulation comprising the composition
US20190388344A1 (en) 2018-06-22 2019-12-26 Probiotech Llc Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor
CN109288069A (zh) * 2018-11-29 2019-02-01 无锡市人民医院 一种可减少腹泻的肠内营养制剂
CN109517759A (zh) * 2018-12-04 2019-03-26 山西大学 一种适于肠道定植、提高消化率和免疫力的枯草芽孢杆菌制剂及其制备方法
US20220168366A1 (en) * 2019-03-01 2022-06-02 Glaxosmithkline Biologicals Sa Nutraceutical compositions
KR102009731B1 (ko) 2019-04-15 2019-08-12 주식회사 쎌바이오텍 단백질 가수분해물을 이용한 단백질-다당류 이중코팅 유산균의 제조방법
KR20220016481A (ko) 2019-06-03 2022-02-09 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 패혈증 및 괴사성 장염 유도된 신경발달 결핍의 예방을 위한 프리바이오틱 제형
CN112189850A (zh) * 2020-09-17 2021-01-08 合生元（广州）健康产品有限公司 益生元在促进胃肠道中益生菌存活的应用
KR102273663B1 (ko) * 2020-10-29 2021-07-05 주식회사 에치와이 코팅 프로바이오틱스 및 이를 포함하는 식품 조성물, 이의 제조방법
US20240228944A9 (en) * 2020-11-30 2024-07-11 Chr. Hansen A/S Method for preparing bacterial products
EP4291045A1 (en) * 2021-02-10 2023-12-20 DSM IP Assets B.V. Powderous composition(ii)
JP2024508212A (ja) * 2021-02-10 2024-02-26 ディーエスエム アイピー アセッツ ビー．ブイ． 粉末状組成物（ｉ）
CN113116941B (zh) * 2021-03-08 2023-05-12 山东晶辉生物技术有限公司 一种可缓解2型糖尿病的益生菌、益生元复合制剂及其制备方法
AU2023339748A1 (en) * 2022-09-09 2025-03-20 Dsm Ip Assets B.V. Fat-soluble vitamin powder for fortifying food products
WO2024076586A2 (en) * 2022-10-03 2024-04-11 Vitakey Inc. Lipid encapsulated probiotic compositions
CN117511772B (zh) * 2023-10-13 2025-01-10 健合香港有限公司 一株动物联合乳杆菌及其应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443540A (en) * 1980-05-09 1984-04-17 University Of Illinois Foundation Protein hydrolysis
US4545933A (en) * 1980-08-20 1985-10-08 Ernster John H Hydrolyzed protein composition and process used in preparation thereof
US4377601A (en) * 1981-09-04 1983-03-22 Miller Brewing Company Method of removing hulls from brewer's spent grain
US4713341A (en) * 1983-09-16 1987-12-15 Bily Robert Raymond Starter cultures of improved activity for dairy products and process of making same
JPS60176549A (ja) * 1984-02-22 1985-09-10 Nisshin Oil Mills Ltd:The たん白分解物の製造法
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
GR861162B (en) * 1985-05-06 1986-09-01 Unilever Nv Improved protein hydrolysate
EP0259739A1 (en) 1986-09-10 1988-03-16 Rhone-Poulenc Inc. Improved stability of freeze-dried cultures
DE68910771T2 (de) * 1988-09-26 1994-03-31 Unilever Nv Verfahren zur Herstellung von verbessertem Proteinhydrolysat.
DD300815A5 (de) * 1989-07-07 1992-08-06 Nestle Sa Proteinhydrolyse
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
IL100733A (en) * 1991-01-24 1995-12-31 Martek Corp Preparations containing a mixture of microbial oils and their preparation
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
US5374567A (en) * 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
RU2214258C2 (ru) 1997-07-05 2003-10-20 Сосьете Де Продюи Нестле С.А. Всасывание минеральных веществ кишечными клетками
US6221423B1 (en) * 1998-04-13 2001-04-24 Protein Technologies Int'l Inc. Short-chained peptide material
WO2001000344A1 (en) * 1999-06-30 2001-01-04 Bechtel Bwxt Idaho, Llc Encapsulation method for maintaining biodecontamination activity
GB0005839D0 (en) * 2000-03-10 2000-05-03 Provita Eurotech Ltd Storage and delivery of micro-organisms
AU2003236689A1 (en) * 2002-06-04 2003-12-19 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
RU2428886C2 (ru) * 2005-04-13 2011-09-20 Нестек С.А. Смесь для грудных детей, содержащая пробиотики
US20060233752A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
WO2006124630A2 (en) * 2005-05-13 2006-11-23 New England Medical Center Hospitals, Inc. Compositions and methods for enhancing the efficacy of vaccines
ATE515198T1 (de) * 2005-05-18 2011-07-15 Dsm Ip Assets Bv Zusammensetzung für die enterale verabreichung von mikroorganismen
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
ES2350907T3 (es) * 2005-07-01 2011-01-28 N.V. Nutricia Nutrición para bebés con proteínas hidrolizadas.
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
US20070048295A1 (en) * 2005-08-23 2007-03-01 Ming-Ju Chen Method for preparing alginate capsules
PL1928426T3 (pl) * 2005-09-29 2015-04-30 Merck Patent Gmbh Sposób stabilizowania farmaceutycznych form podawania zawierających mikroorganizmy
US8524304B2 (en) * 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
JP5047190B2 (ja) * 2005-12-14 2012-10-10 オクセラ インコーポレイテッド シュウ酸塩関連疾患を治療または予防するための医薬組成物および方法
EP1832179B1 (en) * 2005-12-20 2018-11-07 N.V. Nutricia Carbohydrate composition and flat glucose response
NL1032840C2 (nl) * 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
JP5285617B2 (ja) * 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
EP2164350A2 (en) * 2007-07-13 2010-03-24 Unilever N.V. Composition comprising bacteria and lecithin
US10251899B2 (en) * 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
CN106987525B (zh) 2009-05-26 2020-10-27 先进生物营养公司 包含生物活性微生物和/或生物活性材料的稳定干粉组合物及其制造方法
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
US10212954B2 (en) * 2009-12-18 2019-02-26 Colgate-Palmolive Company Pet food compositions including probiotics and methods of manufacture and use thereof
US9504750B2 (en) * 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials

Also Published As

Publication number Publication date
EP2477638A4 (en) 2016-02-24
CA2772534A1 (en) 2011-03-24
WO2011035093A1 (en) 2011-03-24
CN114128892A (zh) 2022-03-04
WO2015084531A1 (en) 2015-06-11
BR112012006220A2 (pt) 2017-06-06
IN2012DN01440A (es) 2015-06-05
EP2477638B1 (en) 2018-07-25
NZ718839A (en) 2021-09-24
CA2929168C (en) 2022-01-04
NZ598520A (en) 2014-02-28
US20110070334A1 (en) 2011-03-24
PH12016500689B1 (en) 2016-05-30
TW201127955A (en) 2011-08-16
CN102573862A (zh) 2012-07-11
US20140093613A1 (en) 2014-04-03
MX2016007007A (es) 2016-09-07
MY171199A (en) 2019-10-01
PH12012500294B1 (en) 2019-02-20
CO6511231A2 (es) 2012-08-31
JP2013505257A (ja) 2013-02-14
SG11201602868WA (en) 2016-05-30
AU2014357609B2 (en) 2017-10-12
EP3079503A1 (en) 2016-10-19
EP2477638A1 (en) 2012-07-25
PH12012500294A1 (en) 2012-10-22
AU2010295508B2 (en) 2016-08-04
ECSP12011820A (es) 2012-05-30
TWI621707B (zh) 2018-04-21
AU2010295508A1 (en) 2012-03-15
CN105792676A (zh) 2016-07-20
JP6240386B2 (ja) 2017-11-29
CN107594537A (zh) 2018-01-19
US20170296600A1 (en) 2017-10-19
MX343446B (es) 2016-11-07
PL2477638T3 (pl) 2018-12-31
AR098598A1 (es) 2016-06-01
RU2012115658A (ru) 2013-10-27
PH12016500689A1 (en) 2016-05-30
MY182617A (en) 2021-01-27
KR20120068851A (ko) 2012-06-27
ES2683310T3 (es) 2018-09-26
TW201531236A (zh) 2015-08-16
CA2929168A1 (en) 2015-06-11
MX2012002527A (es) 2012-04-11

Similar Documents

Publication Publication Date Title
PE20121503A1 (es) Estabilizacion de probioticos
AR081324A1 (es) Produccion de composiciones unificadas de alta densidad
CU20190058A7 (es) Composiciones de aminoácidos relacionadas con mejoras de la función hepática
BR112016028644A2 (pt) composições de célula t aprimoradas
CR20120271A (es) Composiciones lipopéptidas y métodos relacionados
CL2007002084A1 (es) Ingrediente lacteo enriquecido en fosfolipidos y esfingolipidos, en que el porcentaje de fosfolipidos es mayor a 36% con respeto al peso de la materia seca del ingrediente; procedimiento de obtencion; composicion alimentaria o aditivo que lo contiene; composicion farmaceutica o cosmetica; y su uso.
CL2011003003A1 (es) Composicion tensioactiva reconstituida que comprende un polipeptido análogo a la proteína surfactante c nativa, un polipeptido análogo a la proteína surfactante b nativa, un fosfolipido monoinsaturado y un fosfolipido saturado, útil para el tratamiento del síndrome de dificultad respiratoria.
MX339060B (es) Formulaciones del factor viii.
CL2012000508A1 (es) Composicion para la aplicacion en cultivos agricolas al aire libre o invernaderos que comprende zeolita, y aditivos; uso de la composicion para aumentar el rendimiento de los cultivos agricolas.
UY32036A (es) Derivados de ciclohexil-amida, composiciones farmacéuticas que los contienen, su preparación y aplicaciones
ES2721058T3 (es) Polipéptidos bifuncionales
CU23978B1 (es) Composiciones para anticuerpos que se dirigen a la proteína de complemento c5
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
ES2691070T3 (es) Péptidos antiinflamatorios y composición que comprende los mismos
CO6630181A2 (es) Composiciones y métodos para uso de anticuerpos terapéuticos de lrp6( proteina relacionada con lipoproteínas de baja densidad 6)
ES2530624T3 (es) Composiciones de adhesivo
MX2012008717A (es) Composiciones para el cuidado oral.
PA8846101A1 (es) Anticuerpos del receptor ii anti-tgf-beta
MX2011007101A (es) Composiciones de hidrolizados proteicos que tienen capacidad mejorada para liberar colecistocinina (cck).
CO6592060A2 (es) Polvos nutricionales que comprenden hmb secado por aspersión
PE20121795A1 (es) Polvos nutricionales mezclados en seco
ES2616017T3 (es) Composiciones que contienen sulfato de condroitina, nattocinasa y compuestos de sulfhidrilo para su uso en el tratamiento de inflamación
CL2012003458A1 (es) Vector que comprende un polipeptido antigénico de campylobacter; composicion farmacéutica que comprende dicho vector; uso del vector para mejorar respuesta inmune del sujeto al polipéptido antigénico.
EA201290542A1 (ru) Модифицированные свиные соматотропиновые полипептиды и их применение
EA201290541A1 (ru) Модифицированные бычьи соматотропиновые полипептиды и их применение

Legal Events

Date Code Title Description
FC Refusal
AE Restoration of lapsed or forfeited application
FC Refusal